10-104125607-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001002759.2(SFR1):āc.641A>Gā(p.Asn214Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000403 in 1,613,686 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001002759.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SFR1 | NM_001002759.2 | c.641A>G | p.Asn214Ser | missense_variant | 4/4 | ENST00000369727.4 | NP_001002759.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SFR1 | ENST00000369727.4 | c.641A>G | p.Asn214Ser | missense_variant | 4/4 | 2 | NM_001002759.2 | ENSP00000358742 | A1 | |
SFR1 | ENST00000369729.7 | c.602A>G | p.Asn201Ser | missense_variant | 4/4 | 1 | ENSP00000358744 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152210Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000518 AC: 13AN: 251082Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135702
GnomAD4 exome AF: 0.0000219 AC: 32AN: 1461358Hom.: 0 Cov.: 30 AF XY: 0.0000138 AC XY: 10AN XY: 727010
GnomAD4 genome AF: 0.000217 AC: 33AN: 152328Hom.: 0 Cov.: 32 AF XY: 0.000242 AC XY: 18AN XY: 74490
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 11, 2023 | The c.641A>G (p.N214S) alteration is located in exon 4 (coding exon 4) of the SFR1 gene. This alteration results from a A to G substitution at nucleotide position 641, causing the asparagine (N) at amino acid position 214 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at